1-6 of 6
Joan Gilmore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypogammaglobulinemia and Infection Risk in Chronic Lymphocytic Leukemia (CLL) Patients Treated with CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cells

Natalie F. Uy, MD, Edward Pequignot, Noelle V. Frey, MD, Megan Davis, PhD, Elizabeth O. Hexner, MD, Stephen J. Schuster, MD, Saar Gill, MD PhD, Alison W. Loren, MD, Stephan A Grupp, MD PhD, J. Joseph Melenhorst, PhD, Simon F Lacey, PhD, Joseph A Fraietta, PhD, Joan Gilmore, BS, Lester Lledo, RN,NP, Wei-Ting Hwang, PhD, Don L. Siegel, MD PhD, Bruce L Levine, PhD, Carl H June, MD, David L. Porter, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–32.
https://doi.org/10.1182/blood-2020-141224
Published: 2020
Journal Articles

Outcomes in Aggressive B-Cell Non-Hodgkin Lymphomas with Anti-CD19 CAR T-Cell (CTL019) Products Not Meeting Commercial Release Specifications

Elise A. Chong, MD, James N. Gerson, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, David L. Porter, MD, Karen Dengel, BSN, RN, Don L. Siegel, MD PhD, Joan Gilmore, BS, Stefan K. Barta, MD MRCP, MS, Bruce L Levine, PhD, Carl H June, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 594.
https://doi.org/10.1182/blood-2019-131078
Published: 2019
Journal Articles

Randomized, Phase II Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed, Refractory CLL

David L. Porter, MD, Noelle V. Frey, MDMS, J. Joseph Melenhorst, PhD, Wei-Ting Hwang, PhD, Simon F. Lacey, PhD BSc, Pamela Shaw, PhD, Anne Chew, PhD, Stephan A. Grupp, MD PhD, James Capobianchi, Joan Gilmore, Michael Kalos, PhD, Manuel Litchman, MD, Lester Lledo, RN,MSN,CNP, Alison Wakoff Loren, MDMS, Yolanda Mahnke, PhD, Katherine T. Marcucci, PhD, Holly McConville, RN, Angela Shen, MD, Patricia A. Wood, MD PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 1982.
https://doi.org/10.1182/blood.V124.21.1982.1982
Published: 2014
Journal Articles

Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL

David L. Porter, MD, Michael Kalos, PhD, Noelle V. Frey, MD, Stephan A. Grupp, MD, PhD, Alison W. Loren, MD, Christina Jemison, RN, Joan Gilmore, Holly McConville, RN, BSN, James Capobianchi, Lester Lledo, CRNP, Anne Chew, PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 4162.
https://doi.org/10.1182/blood.V122.21.4162.4162
Published: 2013
Journal Articles

Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) In Patients With Relapsed, Refractory CLL

David L. Porter, MD, Michael Kalos, PhD, Noelle V. Frey, MD, Stephan A Grupp, MD, PhD, Alison W. Loren, MD, Christina Jemision, RN, Joan Gilmore, Holly McConville, RN, BSN, James Capobianchi, Lester Lledo, CRNP, Anne Chew, PhD, Angela Shen, MD, Patricia A. Wood, MD, PhD, Manuel Litchman, MD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 873.
https://doi.org/10.1182/blood.V122.21.873.873
Published: 2013
Journal Articles

Chimeric Antigen Receptor T Cells Directed Against CD19 Induce Durable Responses and Transient Cytokine Release Syndrome in Relapsed, Refractory CLL and ALL

David L Porter, MD, Stephan A. Grupp, MD, PhD, Michael Kalos, PhD, Alison W. Loren, MD, Lester Lledo, CRNP, Joan Gilmore, Michael C Milone, MD, PhD, Anne Chew, PhD, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 717.
https://doi.org/10.1182/blood.V120.21.717.717
Published: 2012